Post-remission therapy with allogeneic stem cell transplantation from an HILA-matched family donor in younger patients with acute myeloid leukaemia exhibiting a normal karyotype:: differential effects of molecular markers

被引：0
|
作者：
Schlenk, RF
Corbacioglu, A
Krauter, J
Fröhling, S
Bunjes, D
Späth, D
Schäfer, I
Döhner, H
Ganser, A
Döhner, K
机构：
[1] Univ Ulm, Ulm, Germany
[2] Hannover Med Sch, D-3000 Hannover, Germany
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [41] Peripheral Blood Stem Cells Vs Bone Marrow: Stem Cell Source Comparison for Patients Acute Myeloid Leukemia and Myelodysplastic Syndrome Receiving an Allogeneic Stem Cell Transplantation from a 10/10 Matched Donor. Study from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
    Ravinet, Aurelie
    Cabrespine, Aurelie
    Socie, Gerard
    Milpied, Noel
    Yakoub-Agha, Ibrahim
    Stephanie Nguyen
    Michallet, Mauricette
    Lemasle, Emilie
    Suarez, Felipe
    Maillard, Natacha
    de Latour, Regis Peffault
    Bay, Jacques-Olivier
    BLOOD, 2014, 124 (21)
  • [42] ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA WITH NORMAL CYTOGENETICS (CN-AML): OUTCOME, RISK FACTORS AND ROLE OF MOLECULAR SUBGROUPS IN 1006 PATIENTS - A REPORT FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT
    Schmid, C.
    Labopin, M.
    Socie, G.
    Rambaldi, A.
    Schwerdtfeger, R.
    Deconinck, E.
    Vigouroux, S.
    Huynh, A.
    Volin, L.
    Bourhis, J. -H.
    Maertens, J.
    Chevalier, P.
    Jindra, P.
    Schlimok, G.
    Cornelissen, J.
    Ifrah, N.
    Nagler, A.
    Polge, E.
    Esteve, J.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S69 - S69
  • [43] Allogeneic Stem Cell Transplantation For Acute Myeloid Leukemia With Normal Cytogenetics (CN-AML): Outcome, Risk Factors and Role Of Molecular Subgroups In 752 Patients - A Report From The Acute Leukemia Working Party Of EBMT
    Schmid, Christoph
    Labopin, Myriam
    Socie, Gerard
    Rambaldi, Alessandro
    Schwerdtfeger, Rainer
    Deconinck, Eric
    Vigouroux, Stephane
    Huynh, Anne
    Volin, Liisa
    Bourhis, Jean-Henri
    Maertens, Johan
    Chevalier, Patrice
    Jindra, Pavel
    Schlimok, Guenther
    Cornelissen, Jan
    Ifrah, Norbert
    Nagler, Arnon
    Polge, Emmanuelle
    Esteve, Jordi
    Mohty, Mohamad
    BLOOD, 2013, 122 (21)
  • [44] Mobilized Peripheral Blood Stem Cells Compared with Bone Marrow as the Stem Cell Source for Unrelated Donor Allogeneic Transplantation with Reduced-Intensity Conditioning in Patients with Acute Myeloid Leukemia in Complete Remission: An Analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
    Nagler, Arnon
    Labopin, Myriam
    Shimoni, Avichai
    Niederwieser, Dietger
    Mufti, Ghulam J.
    Zander, Axel R.
    Arnold, Renate
    Greinix, Hildegard
    Cornelissen, Jan J.
    Jackson, Graham H.
    Craddock, Charles
    Bunjes, Donald W.
    Ganser, Arnold
    Russell, Nigel H.
    Kyrcz-Krzemien, Slawomira
    Rocha, Vanderson
    Mohty, Mohamad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (09) : 1422 - 1429
  • [45] Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Salvatore, Dalila
    Labopin, Myriam
    Ruggeri, Annalisa
    Battipaglia, Giorgia
    Ghavamzadeh, Ardeshir
    Ciceri, Fabio
    Blaise, Didier
    Arcese, William
    Socie, Gerard
    Bourhis, Jean Henri
    Van Lint, Maria Teresa
    Bruno, Benedetto
    Huynh, Anne
    Santarone, Stella
    Deconinck, Eric
    Mohty, Mohamad
    Nagler, Arnon
    HAEMATOLOGICA, 2018, 103 (08) : 1317 - 1328
  • [46] Post-remission therapy with 4 cycles of intermediate (I) or high-dose (HD) cytarabine (AC) or autologous hematopoietic stem cell transplantation (ASCT) for acute myeloid leukemia (AML) patients <60 years with normal cytogenetics:: A Cancer and Leukemia Group B (CALGB) Study.
    Farag, SS
    Ruppert, A
    Mrozek, K
    Kolitz, JE
    Mayer, RJ
    Carroll, AJ
    Powell, BL
    Moore, JO
    Larson, RA
    Bloomfield, CD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 568S - 568S
  • [47] Allogeneic transplantation from an HLA-matched family donor in first complete remission of acute myeloid leukemia had an adverse impact on quality of life in patients followed for at least five years after treatment:: A survey of the German AML intergroup on 525 patients.
    Messerer, D
    Engel, J
    Hasford, J
    Schaich, M
    Soucek, S
    Ehninger, G
    Sauerland, C
    Büchner, T
    Niederwieser, DW
    Krahl, R
    Krauter, J
    Schäfer, I
    Ganser, A
    Schleich, C
    Döhner, H
    Schlenk, RF
    BLOOD, 2005, 106 (11) : 221A - 221A
  • [48] Azacitidine and donor lymphocyte infusions as first salvage treatment in patients with acute myeloid leukaemia or myelodysplastic syndromes relapsing after allogeneic stem cell transplantation: interim-analysis from the AZARELA-trial (NCT-00795548)
    Schroeder, T.
    Czibere, A.
    Kroeger, N.
    Platzbecker, U.
    Bug, G.
    Uharek, L.
    Luft, T.
    Bruns, I.
    Zohren, F.
    Wolschke, C.
    Fenk, R.
    Haas, R.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S79 - S79
  • [49] Haploidentical Mismatched Allogeneic Versus Autologous Hematopoietic STEM CELL Transplantation in Adult Patients with ACUTE Myeloid Leukemia (AML) in First Complete Remission (CR1): A Pair-Matched Analysis From the Acute Leukemia Working Party of EBMT.
    Gorin, Norbert C.
    Labopin, Myriam
    Ciceri, Fabio
    Velardi, Andrea
    Santarone, Stella
    Arcese, William
    Mohty, Mohamad
    BLOOD, 2012, 120 (21)
  • [50] Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation
    Pasquini, Marcelo C.
    Devine, Steven
    Mendizabal, Adam
    Baden, Lindsey R.
    Wingard, John R.
    Lazarus, Hillard M.
    Appelbaum, Frederick R.
    Keever-Taylor, Carolyn A.
    Horowitz, Mary M.
    Carter, Shelly
    O'Reilly, Richard J.
    Soiffer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3194 - 3201
12345